Clinical trial
Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin…
NCT00310778 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00310778 |
|---|---|
| Title | Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker |
| Official title | Effects of Sodium Intake on Pharmacokinetic/Pharmacodynamic Relationship of a Single Dose of a Renin Angiotensin System-Blocker, or a Beta-Blocker in Normotensive Sodium-Depleted or Replated Volunteers in a Cross-Over Study |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | high sodium diet, low sodium diet, ramipril 10 mg, valsartan 160 mg, candesartan 8 mg, atenolol 50 mg |
| Enrollment | 64 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Apr 4, 2006 |
| Last update posted | Sep 22, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: